Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc.（TCRT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tcrt · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年5月30日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Hold
10 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.00
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.94 | ↓ 3.02% |
1-day model range: $1.9–$1.98. Peak: $1.98 (-3.02%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -44.6% |
| 2028 | — | -57.0% |
| 2029 | — | -61.8% |
| 2030 | — | -63.9% |
| 2031 | — | -64.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · TCRT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-08-14 | Laidlaw & Co. | Downgrade ↓ | Buy→Hold |
| 2023-05-14 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2022-05-03 | Wells Fargo | Upgrade ↑ | Equal Weight→Overweight |
| 2021-11-08 | Raymond James | Maintains | Market Perform→Market Perform |
| 2021-08-09 | Raymond James | Downgrade ↓ | Outperform→Market Perform |
| 2021-05-06 | Raymond James | Maintains | Outperform→Outperform |
| 2021-03-11 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2021-02-28 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2020-03-02 | Raymond James | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Alaunos Therapeutics, Inc. (TCRT) stock. Of the recent 24 rating actions, 6 were upgrades and 13 were downgrades. 10 analysts currently cover TCRT.
分析师推荐趋势
TCRT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
↑ 66.7% YoY
EPS This Year
$-1.67
EPS Next Year
$-6.00
↑ 258.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast TCRT EPS of $-1.67 for the current fiscal year, based on estimates from 1 analysts. The TCRT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TCRT 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TCRT 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
TCRT 的短期预测（明日）为 $1.94（-3.02%）。 TCRT 对 2030 年的预测区间为 $1–$1。
Alaunos Therapeutics, Inc. 在 NASDAQ 上市，代码 TCRT。TCRT 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 10% 对应 Hold 共识。
常见问题
TCRT 预测 · 8 个问题根据 10 位华尔街分析师，TCRT 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $2.00，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.